Omnicell (OMCL) 10-Q 4 Aug 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2023	Jul. 28, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	000-33043
Entity Registrant Name	OMNICELL, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3166458
Entity Address, Address Line One	4220 North Freeway
Entity Address, City or Town	Fort Worth
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	76137
City Area Code	877
Local Phone Number	415-9990
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	OMCL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		45,212,042
Entity Central Index Key	0000926326
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 399,464	$ 330,362
Accounts receivable and unbilled receivables, net of allowances of $5,766 and $5,153, respectively	273,899	299,469
Inventories	130,577	147,549
Prepaid expenses	23,514	27,070
Other current assets	53,907	77,362
Total current assets	881,361	881,812
Property and equipment, net	103,212	93,961
Long-term investment in sales-type leases, net	35,039	32,924
Operating lease right-of-use assets	27,698	38,052
Goodwill	735,523	734,274
Intangible assets, net	226,707	242,906
Long-term deferred tax assets	32,764	22,329
Prepaid commissions	54,777	59,483
Other long-term assets	96,791	105,017
Total assets	2,193,872	2,210,758
Current liabilities:
Accounts payable	47,192	63,389
Accrued compensation	52,475	73,455
Accrued liabilities	145,888	172,655
Deferred revenues, net	124,602	118,947
Total current liabilities	370,157	428,446
Long-term deferred revenues	48,750	37,385
Long-term deferred tax liabilities	1,511	2,095
Long-term operating lease liabilities	35,510	39,405
Other long-term liabilities	6,265	6,719
Convertible senior notes, net	568,114	566,571
Total liabilities	1,030,307	1,080,621
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued	0	0
Common stock, $0.001 par value, 100,000 shares authorized; 55,488 and 55,030 shares issued; 45,205 and 44,747 shares outstanding, respectively	56	55
Treasury stock at cost, 10,283 shares outstanding, respectively	(290,319)	(290,319)
Additional paid-in capital	1,088,825	1,046,760
Retained earnings	379,179	390,728
Accumulated other comprehensive loss	(14,176)	(17,087)
Total stockholders’ equity	1,163,565	1,130,137
Total liabilities and stockholders’ equity	$ 2,193,872	$ 2,210,758

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowance for credit losses on accounts receivable and unbilled receivables	$ 5,766	$ 5,153
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000	5,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000	100,000
Common Stock, shares issued (in shares)	55,488	55,030
Common stock, shares outstanding (in shares)	45,205	44,747
Treasury stock, shares outstanding (in shares)	10,283	10,283

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues	$ 298,973	$ 331,386	$ 589,602	$ 650,214
Cost of revenues	164,530	173,294	330,130	342,075
Gross profit	134,443	158,092	259,472	308,139
Operating expenses:
Research and development	23,137	26,355	46,015	51,385
Selling, general, and administrative	103,558	119,252	228,672	239,185
Total operating expenses	126,695	145,607	274,687	290,570
Income (loss) from operations	7,748	12,485	(15,215)	17,569
Interest and other income (expense), net	4,461	(1,711)	6,242	(1,825)
Income (loss) before income taxes	12,209	10,774	(8,973)	15,744
Provision for (benefit from) income taxes	8,758	1,705	2,576	(1,538)
Net income (loss)	$ 3,451	$ 9,069	$ (11,549)	$ 17,282
Net income (loss) per share:
Basic (in dollars per share)	$ 0.08	$ 0.21	$ (0.26)	$ 0.39
Diluted (in dollars per share)	$ 0.08	$ 0.20	$ (0.26)	$ 0.37
Weighted-average shares outstanding:
Basic (in shares)	45,125	44,219	45,007	44,234
Diluted (in shares)	45,472	46,260	45,007	47,121
Product revenues
Revenues	$ 188,436	$ 233,806	$ 374,151	$ 459,681
Cost of revenues	107,962	121,814	217,489	240,152
Services and other revenues
Revenues	110,537	97,580	215,451	190,533
Cost of revenues	$ 56,568	$ 51,480	$ 112,641	$ 101,923

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 3,451	$ 9,069	$ (11,549)	$ 17,282
Other comprehensive income (loss):
Foreign currency translation adjustments	1,432	(6,410)	2,911	(8,965)
Other comprehensive income (loss)	1,432	(6,410)	2,911	(8,965)
Comprehensive income (loss)	$ 4,883	$ 2,659	$ (8,638)	$ 8,317

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative effect of a change in accounting principle related to convertible debt	Common Stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative effect of a change in accounting principle related to convertible debt	Retained Earnings	Retained Earnings Cumulative effect of a change in accounting principle related to convertible debt	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2021			54,073,000
Balance at beginning of period at Dec. 31, 2021	$ 1,146,689	$ (56,233)	$ 54	$ (238,109)	$ 1,024,580	$ (72,742)	$ 368,571	$ 16,509	$ (8,407)
Balance at beginning of period, Treasury stock (in shares) at Dec. 31, 2021				(9,894,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,213						8,213
Other comprehensive income (loss)	(2,555)								(2,555)
Share-based compensation	16,208				16,208
Issuance of common stock under employee stock plans (in shares)			384,000
Issuance of common stock under employee stock plans	18,951				18,951
Tax payments related to restricted stock units	(4,322)				(4,322)
Stock repurchases (in shares)				(389,000)
Stock repurchases	(52,210)			$ (52,210)
Balance at end of period (in shares) at Mar. 31, 2022			54,457,000
Balance at end of period at Mar. 31, 2022	1,074,741		$ 54	$ (290,319)	982,675		393,293		(10,962)
Balance at end of period, Treasury stock (in shares) at Mar. 31, 2022				(10,283,000)
Balance at beginning of period (in shares) at Dec. 31, 2021			54,073,000
Balance at beginning of period at Dec. 31, 2021	1,146,689	$ (56,233)	$ 54	$ (238,109)	1,024,580	$ (72,742)	368,571	$ 16,509	(8,407)
Balance at beginning of period, Treasury stock (in shares) at Dec. 31, 2021				(9,894,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	17,282
Other comprehensive income (loss)	(8,965)
Balance at end of period (in shares) at Jun. 30, 2022			54,571,000
Balance at end of period at Jun. 30, 2022	1,092,637		$ 55	$ (290,319)	997,911		402,362		(17,372)
Balance at end of period, Treasury stock (in shares) at Jun. 30, 2022				(10,283,000)
Balance at beginning of period (in shares) at Mar. 31, 2022			54,457,000
Balance at beginning of period at Mar. 31, 2022	1,074,741		$ 54	$ (290,319)	982,675		393,293		(10,962)
Balance at beginning of period, Treasury stock (in shares) at Mar. 31, 2022				(10,283,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	9,069						9,069
Other comprehensive income (loss)	(6,410)								(6,410)
Share-based compensation	17,213				17,213
Issuance of common stock under employee stock plans (in shares)			114,000
Issuance of common stock under employee stock plans	2,172		$ 1		2,171
Tax payments related to restricted stock units	(4,148)				(4,148)
Balance at end of period (in shares) at Jun. 30, 2022			54,571,000
Balance at end of period at Jun. 30, 2022	$ 1,092,637		$ 55	$ (290,319)	997,911		402,362		(17,372)
Balance at end of period, Treasury stock (in shares) at Jun. 30, 2022				(10,283,000)
Balance at beginning of period (in shares) at Dec. 31, 2022	44,747,000		55,030,000
Balance at beginning of period at Dec. 31, 2022	$ 1,130,137		$ 55	$ (290,319)	1,046,760		390,728		(17,087)
Balance at beginning of period, Treasury stock (in shares) at Dec. 31, 2022	(10,283,000)			(10,283,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (15,000)						(15,000)
Other comprehensive income (loss)	1,479								1,479
Share-based compensation	15,180				15,180
Issuance of common stock under employee stock plans (in shares)			322,000
Issuance of common stock under employee stock plans	12,114				12,114
Tax payments related to restricted stock units	(1,369)				(1,369)
Balance at end of period (in shares) at Mar. 31, 2023			55,352,000
Balance at end of period at Mar. 31, 2023	$ 1,142,541		$ 55	$ (290,319)	1,072,685		375,728		(15,608)
Balance at end of period, Treasury stock (in shares) at Mar. 31, 2023				(10,283,000)
Balance at beginning of period (in shares) at Dec. 31, 2022	44,747,000		55,030,000
Balance at beginning of period at Dec. 31, 2022	$ 1,130,137		$ 55	$ (290,319)	1,046,760		390,728		(17,087)
Balance at beginning of period, Treasury stock (in shares) at Dec. 31, 2022	(10,283,000)			(10,283,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ (11,549)
Other comprehensive income (loss)	$ 2,911
Balance at end of period (in shares) at Jun. 30, 2023	45,205,000		55,488,000
Balance at end of period at Jun. 30, 2023	$ 1,163,565		$ 56	$ (290,319)	1,088,825		379,179		(14,176)
Balance at end of period, Treasury stock (in shares) at Jun. 30, 2023	(10,283,000)			(10,283,000)
Balance at beginning of period (in shares) at Mar. 31, 2023			55,352,000
Balance at beginning of period at Mar. 31, 2023	$ 1,142,541		$ 55	$ (290,319)	1,072,685		375,728		(15,608)
Balance at beginning of period, Treasury stock (in shares) at Mar. 31, 2023				(10,283,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,451						3,451
Other comprehensive income (loss)	1,432								1,432
Share-based compensation	15,148				15,148
Issuance of common stock under employee stock plans (in shares)			136,000
Issuance of common stock under employee stock plans	3,089		$ 1		3,088
Tax payments related to restricted stock units	$ (2,096)				(2,096)
Balance at end of period (in shares) at Jun. 30, 2023	45,205,000		55,488,000
Balance at end of period at Jun. 30, 2023	$ 1,163,565		$ 56	$ (290,319)	$ 1,088,825		$ 379,179		$ (14,176)
Balance at end of period, Treasury stock (in shares) at Jun. 30, 2023	(10,283,000)			(10,283,000)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Operating Activities
Net income (loss)	$ (11,549)	$ 17,282
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	44,054	43,017
Loss on disposal of property and equipment	993	0
Share-based compensation expense	28,131	33,421
Deferred income taxes	(11,019)	(9,506)
Amortization of operating lease right-of-use assets	4,225	6,801
Impairment and abandonment of operating lease right-of-use assets related to facilities	7,815	5,093
Amortization of debt issuance costs	2,091	2,079
Changes in operating assets and liabilities:
Accounts receivable and unbilled receivables	26,463	(71,418)
Inventories	17,820	(32,625)
Prepaid expenses	3,576	1,660
Other current assets	773	(1,996)
Investment in sales-type leases	(1,707)	(12,465)
Prepaid commissions	4,706	6,033
Other long-term assets	43	1,455
Accounts payable	(15,806)	(3,130)
Accrued compensation	(20,980)	(11,118)
Accrued liabilities	(4,646)	4,682
Deferred revenues	16,540	1,395
Operating lease liabilities	(5,396)	(7,176)
Other long-term liabilities	(454)	969
Net cash provided by (used in) operating activities	85,673	(25,547)
Investing Activities
External-use software development costs	(6,685)	(6,543)
Purchases of property and equipment	(21,772)	(21,099)
Business acquisition, net of cash acquired	0	(3,392)
Purchase price adjustments from business acquisitions	0	5,484
Net cash used in investing activities	(28,457)	(25,550)
Financing Activities
Proceeds from issuances under stock-based compensation plans	15,203	21,123
Employees’ taxes paid related to restricted stock units	(3,465)	(8,470)
Change in customer funds, net	(4,273)	5,986
Stock repurchases	0	(52,210)
Net cash provided by (used in) financing activities	7,465	(33,571)
Effect of exchange rate changes on cash and cash equivalents	148	(2,123)
Net increase (decrease) in cash, cash equivalents, and restricted cash	64,829	(86,791)
Cash, cash equivalents, and restricted cash at beginning of period	352,835	355,620
Cash, cash equivalents, and restricted cash at end of period	417,664	268,829
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	399,464	244,953
Restricted cash included in other current assets	18,200	23,876
Cash, cash equivalents, and restricted cash at end of period	417,664	268,829
Supplemental disclosure of non-cash investing activities
Unpaid purchases of property and equipment	464	1,444
Transfers between inventory and property and equipment, net	$ 0	$ 314

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Organization and Summary of Significant Accounting Policies	Organization and Summary of Significant Accounting Policies Business Omnicell, Inc. was incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company’s major products and related services are medication management solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare industry. The Company’s market is primarily located in the United States and Europe. “Omnicell” or the “Company” refer to Omnicell, Inc. and its subsidiaries, collectively. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the financial position of the Company as of June 30, 2023 and December 31, 2022, the results of operations and comprehensive income (loss) for the three and six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and accompanying Notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 1, 2023, except as discussed in the section entitled “Recently Adopted Authoritative Guidance” below. The Company’s results of operations and comprehensive income (loss) for the three and six months ended June 30, 2023, and cash flows for the six months ended June 30, 2023 are not necessarily indicative of results that may be expected for the year ending December 31, 2023, or for any future period. Principles of Consolidation The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Condensed Consolidated Financial Statements and accompanying Notes. These estimates are based on historical experience and various other assumptions that management believes to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. As of June 30, 2023, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Segment Reporting The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment. Recently Adopted Authoritative Guidance In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . The update addresses diversity in practice by requiring that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 beginning January 1, 2023 and will apply the guidance prospectively to acquisitions occurring on or after the adoption date. Recently Issued Authoritative Guidance There was no recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Condensed Consolidated Financial Statements through the reporting date.

Revenues

Revenues	6 Months Ended
	Jun. 30, 2023
Revenue Recognition [Abstract]
Revenues	Revenues Revenue Recognition The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories: Connected devices, software licenses, and other. Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements. Solutions in this category include, but are not limited to, XT Series automated dispensing systems and products related to the Central Pharmacy Dispensing Service and IV Compounding Service. Consumables. Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards, which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, are designed to improve patient engagement and adherence to prescriptions. Technical services. Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements. Advanced Services. Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth ® , Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, other software solutions, and services related to the Central Pharmacy Dispensing Service and IV Compounding Service. The following table summarizes revenue recognition for each revenue category: Revenue Category Timing of Revenue Recognition Income Statement Classification Connected devices, software licenses, and other Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer Product Consumables Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer Product Technical services Over time, as services are provided, typically ratably over the service term Service Advanced Services Over time, as services are provided Service A portion of the Company’s sales are made to customers who are members of Group Purchasing Organizations (“GPOs”) and Federal agencies that purchase under a Federal Supply Schedule Contract with the Department of Veterans Affairs (the “GSA Contract”). GPOs are often fully or partially owned by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company also pays the Industrial Funding Fee (“IFF”) to the Department of Veterans Affairs under the GSA Contract. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs and the IFF were $2.8 million and $4.0 million for the three months ended June 30, 2023 and 2022, respectively, and $5.9 million and $8.5 million for the six months ended June 30, 2023 and 2022, respectively. Disaggregation of Revenues The following table summarizes the Company’s revenues disaggregated by revenue type for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Connected devices, software licenses, and other $ 167,475 $ 215,632 $ 332,622 $ 423,710 Consumables 20,961 18,174 41,529 35,971 Technical services 57,191 53,303 110,548 102,472 Advanced Services 53,346 44,277 104,903 88,061 Total revenues $ 298,973 $ 331,386 $ 589,602 $ 650,214 The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) United States $ 257,202 $ 294,937 $ 513,145 $ 582,514 Rest of world (1) 41,771 36,449 76,457 67,700 Total revenues $ 298,973 $ 331,386 $ 589,602 $ 650,214 _________________________________________________ (1) No individual country represented more than 10% of total revenues. Contract Assets and Contract Liabilities The following table reflects the Company’s contract assets and contract liabilities: June 30, December 31, (In thousands) Short-term unbilled receivables, net (1) $ 22,111 $ 25,763 Long-term unbilled receivables, net (2) 15,132 14,744 Total contract assets $ 37,243 $ 40,507 Short-term deferred revenues, net $ 124,602 $ 118,947 Long-term deferred revenues 48,750 37,385 Total contract liabilities $ 173,352 $ 156,332 _________________________________________________ (1) Included in accounts receivable and unbilled receivables in the Condensed Consolidated Balance Sheets. (2) Included in other long-term assets in the Condensed Consolidated Balance Sheets. The portion of the transaction price allocated to the Company’s unsatisfied performance obligations for which invoicing has occurred is recorded as deferred revenues. Short-term deferred revenues of $124.6 million and $118.9 million include deferred revenues from product sales and service contracts, net of deferred cost of sales of $13.6 million and $15.8 million, as of June 30, 2023 and December 31, 2022, respectively. During the three and six months ended June 30, 2023, the Company recognized revenues of $30.6 million and $86.1 million, respectively, that were included in the corresponding gross short-term deferred revenues balance of $134.7 million as of December 31, 2022. Long-term deferred revenues include deferred revenues from product sales and service contracts of $48.8 million and $37.4 million as of June 30, 2023 and December 31, 2022, respectively. Deferred revenues from product sales primarily relate to delivered and invoiced products, pending installation and acceptance. Deferred revenues from service contracts primarily relate to services that have been invoiced, where services have not yet been provided. Short-term deferred revenues are expected to be recognized within the next twelve months. Long-term deferred revenues substantially consist of deferred revenues on long-term service contracts which have been invoiced and are expected to be recognized as revenue beyond twelve months, generally not more than ten years. The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements is generally periodic and is billed on a monthly, quarterly, or annual basis, and in certain circumstances, multiple years are billed at one time. In addition, the Company has remaining performance obligations associated with contracts for which the associated products have been accepted or associated services have started, but where invoicing has not yet occurred and therefore are not reflected in deferred revenue. These remaining performance obligations are comprised of the non-variable portions of technical services and Advanced Services provided under non-cancellable contracts with minimum commitments. Remaining performance obligations which are not included in deferred revenues are $288.7 million as of June 30, 2023. Remaining performance obligations are expected to be recognized ratably over the remaining term of the contract, which is generally not more than ten years. Remaining performance obligations do not include product obligations, services where the associated product has not been accepted, services which have not yet started, variable portions of services, and certain other obligations. Significant Customers There were no customers that accounted for more than 10% of the Company’s total revenues for the three and six months ended June 30, 2023 and 2022. Also, there were no customers that accounted for more than 10% of the Company’s accounts receivable balance as of June 30, 2023 and December 31, 2022.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share The basic and diluted net income (loss) per share calculations for the three and six months ended June 30, 2023 and 2022 were as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands, except per share data) Net income (loss) $ 3,451 $ 9,069 $ (11,549) $ 17,282 Weighted-average shares outstanding – basic 45,125 44,219 45,007 44,234 Effect of dilutive securities from stock award plans 347 1,142 — 1,421 Effect of convertible senior notes — 899 — 1,466 Weighted-average shares outstanding – diluted 45,472 46,260 45,007 47,121 Net income (loss) per share – basic $ 0.08 $ 0.21 $ (0.26) $ 0.39 Net income (loss) per share – diluted $ 0.08 $ 0.20 $ (0.26) $ 0.37 Anti-dilutive weighted-average shares related to stock award plans 2,512 865 3,530 473 Anti-dilutive weighted-average shares related to convertible senior notes and warrants 11,816 5,908 11,816 5,908

Cash and Cash Equivalents and F

Cash and Cash Equivalents and Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Cash and Cash Equivalents and Fair Value of Financial Instruments	Cash and Cash Equivalents and Fair Value of Financial Instruments Cash and cash equivalents of $399.5 million and $330.4 million as of June 30, 2023 and December 31, 2022, respectively, consisted of bank accounts and highly-liquid U.S. Government money market funds held in sweep and asset management accounts with financial institutions of high credit quality. As of June 30, 2023 and December 31, 2022, cash equivalents were $382.1 million and $301.0 million, respectively, which consisted of money market funds held in sweep and asset management accounts. Fair Value Hierarchy The Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company’s credit facility is classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company’s convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period. As of June 30, 2023 and December 31, 2022, the fair value of the convertible senior notes was $581.6 million and $501.4 million, respectively, compared to their carrying values of $568.1 million and $566.6 million, respectively, which are net of unamortized debt issuance costs. Refer to Note 9, Debt and Credit Agreement, for further information regarding the Company’s credit facility and Note 10, Convertible Senior Notes,

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Balance sheet details as of June 30, 2023 and December 31, 2022 are presented in the tables below: June 30, December 31, (In thousands) Inventories: Raw materials $ 62,757 $ 75,854 Work in process 1,331 9,280 Finished goods 66,489 62,415 Total inventories $ 130,577 $ 147,549 Other current assets: Funds held for customers, including restricted cash (1) $ 34,429 $ 56,703 Net investment in sales-type leases, current portion 11,078 11,486 Prepaid income taxes 63 1,702 Other current assets 8,337 7,471 Total other current assets $ 53,907 $ 77,362 Other long-term assets: External-use software development costs, net $ 73,125 $ 80,760 Unbilled receivables, net 15,132 14,744 Deferred debt issuance costs 1,510 2,058 Other long-term assets 7,024 7,455 Total other long-term assets $ 96,791 $ 105,017 Accrued liabilities: Operating lease liabilities, current portion $ 10,951 $ 10,761 Customer fund liabilities 34,429 56,703 Advance payments from customers 11,547 11,556 Rebate liabilities 46,680 42,802 Group purchasing organization fees 5,428 7,723 Taxes payable 12,337 9,642 Other accrued liabilities 24,516 33,468 Total accrued liabilities $ 145,888 $ 172,655 _________________________________________________ (1) Includes restricted cash of $18.2 million and $22.5 million as of June 30, 2023 and December 31, 2022, respectively. The following table summarizes the changes in accumulated balances of other comprehensive income (loss), which consisted of foreign currency translation adjustments, for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Beginning balance $ (15,608) $ (10,962) $ (17,087) $ (8,407) Other comprehensive income (loss) 1,432 (6,410) 2,911 (8,965) Ending balance $ (14,176) $ (17,372) $ (14,176) $ (17,372)

Property and Equipment

Property and Equipment	6 Months Ended
	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment The following table represents the property and equipment balances as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Equipment $ 97,048 $ 91,391 Furniture and fixtures 4,915 5,154 Leasehold improvements 18,841 19,510 Purchased software and internal-use software development costs 93,396 76,327 Construction in progress 27,564 28,223 Property and equipment, gross 241,764 220,605 Accumulated depreciation and amortization (138,552) (126,644) Total property and equipment, net $ 103,212 $ 93,961 Depreciation and amortization expense of property and equipment was $6.6 million and $5.6 million for the three months ended June 30, 2023 and 2022, respectively, and $12.9 million and $10.9 million for the six months ended June 30, 2023 and 2022, respectively. The geographic location of the Company’s property and equipment, net, is based on the physical location in which it is located. The following table summarizes the geographic information for property and equipment, net, as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) United States $ 99,383 $ 89,989 Rest of world (1) 3,829 3,972 Total property and equipment, net $ 103,212 $ 93,961 _________________________________________________ (1) No individual country represented more than 10% of total property and equipment, net.

External-Use Software Developme

External-Use Software Development Costs	6 Months Ended
	Jun. 30, 2023
Research and Development [Abstract]
External-Use Software Development Costs	External-Use Software Development Costs The carrying amounts of external-use software development costs as of June 30, 2023 and December 31, 2022 were as follows: June 30, December 31, (In thousands) Gross carrying amount $ 232,199 $ 225,004 Accumulated amortization (159,074) (144,244) External-use software development costs, net (1) $ 73,125 $ 80,760 _________________________________________________ (1) Included in other long-term assets in the Condensed Consolidated Balance Sheets. The Company recorded $7.4 million and $7.5 million to cost of revenues for amortization of external-use software development costs for the three months ended June 30, 2023 and 2022, respectively, and $14.8 million and $14.2 million for the six months ended June 30, 2023 and 2022, respectively. The estimated future amortization expenses for external-use software development costs were as follows: June 30, (In thousands) Remaining six months of 2023 $ 14,090 2024 24,219 2025 16,843 2026 11,304 2027 5,349 Thereafter 1,320 Total $ 73,125

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The following table represents changes in the carrying amount of goodwill: (In thousands) Balance as of December 31, 2022 $ 734,274 Foreign currency exchange rate fluctuations 1,249 Balance as of June 30, 2023 $ 735,523 Intangible Assets, Net The carrying amounts and useful lives of intangible assets as of June 30, 2023 and December 31, 2022 were as follows: June 30, 2023 Gross carrying Accumulated Foreign currency exchange Net carrying Useful life (In thousands, except for years) Customer relationships $ 311,089 $ (109,038) $ (1,350) $ 200,701 4 - 30 Acquired technology 92,066 (69,641) — 22,425 4 - 20 Backlog 1,800 (1,350) — 450 2 Trade names 9,200 (7,156) — 2,044 5 - 12 Patents 2,430 (1,393) — 1,037 2 - 20 Non-compete agreements 600 (550) — 50 3 Total intangibles assets, net $ 417,185 $ (189,128) $ (1,350) $ 226,707 December 31, 2022 Gross carrying Accumulated Foreign currency exchange Net carrying Useful life (In thousands, except for years) Customer relationships $ 311,089 $ (99,177) $ (1,514) $ 210,398 4 - 30 Acquired technology 92,066 (64,299) — 27,767 4 - 20 Backlog 1,800 (900) — 900 2 Trade names 9,200 (6,633) — 2,567 5 - 12 Patents 2,430 (1,306) — 1,124 2 - 20 Non-compete agreements 600 (450) — 150 3 Total intangibles assets, net $ 417,185 $ (172,765) $ (1,514) $ 242,906 Amortization expense of intangible assets was $8.1 million and $8.9 million for the three months ended June 30, 2023 and 2022, respectively, and $16.4 million and $18.0 million for the six months ended June 30, 2023 and 2022, respectively. The estimated future amortization expenses for amortizable intangible assets were as follows: June 30, (In thousands) Remaining six months of 2023 $ 15,194 2024 23,086 2025 21,062 2026 18,077 2027 16,800 Thereafter 132,488 Total $ 226,707

Debt and Credit Agreement

Debt and Credit Agreement	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Debt and Credit Agreement	Debt and Credit Agreement 2019 Revolving Credit Facility On November 15, 2019, the Company entered into an Amended and Restated Credit Agreement (as subsequently amended as discussed below, the “A&R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers, and Wells Fargo Bank, National Association, as administrative agent. The A&R Credit Agreement superseded the Company’s 2016 secured credit facility and provides for (a) a five-year revolving credit facility of $500.0 million (the “Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million (the “Incremental Facility”). In addition, the A&R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. The A&R Credit Agreement has an expiration date of November 15, 2024, upon which date all remaining outstanding borrowings will be due and payable. On September 22, 2020, the parties entered into a first amendment to the A&R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions, as described in Note 10, Convertible Senior Notes , expand the Company’s flexibility to repurchase its common stock and make other restricted payments, and replace the total net leverage covenant with a new secured net leverage covenant that requires the Company to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter. The availability of funds under the Revolving Credit Facility may be subject to reduction in order to maintain compliance with the financial covenants under the A&R Credit Agreement. On March 29, 2023, the parties entered into a second amendment to the A&R Credit Agreement to remove and replace the interest rate benchmark based on the London interbank offered rate (“LIBOR”) and related LIBOR-based mechanics applicable to borrowings under the A&R Credit Agreement with an interest rate benchmark based on the secured overnight financing rate (“SOFR”) as administered by the Federal Reserve Bank of New York (including a customary credit spread adjustment of 0.10% per annum) and related SOFR-based mechanics. The replacement of LIBOR did not, and the Company does not anticipate that it will, materially impact its liquidity or financial position. Following the second amendment to the A&R Credit Agreement, loans under the Revolving Credit Facility bear interest, at the Company’s option, at a rate equal to either (a) the Adjusted Term SOFR (as defined in the A&R Credit Agreement), plus an applicable margin ranging from 1.25% to 2.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the A&R Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50%, and (iii) Adjusted Term SOFR for a one month tenor plus 1.00%, plus an applicable margin ranging from 0.25% to 1.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio. Undrawn commitments under the Revolving Credit Facility are subject to a commitment fee ranging from 0.15% to 0.30% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Revolving Credit Facility. The applicable margin for, and certain other terms of, any term loans under the Incremental Facility will be determined prior to the incurrence of such loans. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty. The A&R Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends, and other distributions. The A&R Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum total secured net leverage ratio (as described above) and maintain a minimum interest coverage ratio. In addition, the A&R Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal, and fees, or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults, and events of bankruptcy. The Company’s obligations under the A&R Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and such subsidiary guarantors’ assets. In connection with entering into the A&R Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a reaffirmation agreement, which amends certain terms of the existing collateral agreement and reaffirms their obligations under the existing guaranty agreement. The Company was in compliance with all covenants as of June 30, 2023. As of June 30, 2023 and December 31, 2022, the Company had $417.7 million and $500.0 million of funds available under the Revolving Credit Facility, respectively. As of June 30, 2023 and December 31, 2022, the Company had no outstanding balance under the Revolving Credit Facility. 0.25% Convertible Senior Notes due 2025 On September 25, 2020, the Company completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. The Company received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes were issued pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 15, 2025, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ended on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Notes on each such trading day; (iii) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; and (iv) upon the occurrence of specified corporate events, as specified in the Indenture. On or after May 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing conditions. During the three months ended June 30, 2023 and December 31, 2022, none of the conditional conversion features of the Notes were triggered, and therefore, the Notes are not convertible during the third quarter of 2023, commencing on July 1, 2023, and were not convertible during the first quarter of 2023, commencing on January 1, 2023, respectively. Accordingly, the Company classified the Notes as a long-term liability in its Condensed Consolidated Financial Statements as of both June 30, 2023 and December 31, 2022. Whether the Notes will be convertible following the third fiscal quarter of 2023 will depend on the satisfaction of the conversion conditions in the future. Under the original terms of the Indenture, upon conversion, the Company could satisfy its conversion obligation by paying or delivering cash, shares of its common stock, or a combination thereof, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. On December 13, 2021, the Company irrevocably elected to fix its settlement method to a combination of cash and shares of the Company’s common stock with the specified cash amount per $1,000 principal amount of Notes of at least $1,000. As a result, for Notes converted on or after December 13, 2021, a converting noteholder will receive (i) up to $1,000 in cash per $1,000 principal amount of Notes and (ii) cash and/or shares of the Company’s common stock, at the Company’s option for any conversion consideration in excess of $1,000. In addition, the Company continues to have the ability to set the specified cash amount per $1,000 principal amount of Notes above $1,000. The initial conversion rate for the Notes is 10.2751 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $97.32 per share of the Company’s common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that could occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes (or any portion thereof) in connection with such a corporate event or convert its Notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be. If the Company undergoes a fundamental change, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. As of June 30, 2023, none of the criteria for a fundamental change or a conversion rate adjustment had been met. The Company may not redeem the Notes prior to September 20, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on or after September 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all of the outstanding Notes, at least $150.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for in the Notes. The debt issuance costs associated with the Notes are being amortized to interest expense over the term of the Notes using an effective interest rate of 0.80%. As of June 30, 2023, the remaining life of the Notes and the related issuance cost accretion is approximately 2.2 years. The maximum number of shares issuable upon conversion, including the effect of a fundamental change and subject to other conversion rate adjustments, would be 5.9 million shares. As of June 30, 2023, the if-converted value of the Notes did not exceed the principal amount. The Notes consisted of the following balances reported in the Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Principal amount $ 575,000 $ 575,000 Unamortized debt issuance costs (6,886) (8,429) Convertible senior notes, net $ 568,114 $ 566,571 The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Contractual coupon interest $ 359 $ 359 $ 719 $ 719 Amortization of debt issuance costs $ 772 $ 766 $ 1,543 $ 1,530 Convertible Note Hedge and Warrant Transactions In connection with the issuance of the Notes in September 2020, the Company entered into convertible note hedge and warrant transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”) with respect to the Company’s common stock. The convertible note hedge consists of an option for the Company to purchase up to approximately 5.9 million shares of the Company’s common stock, which is equal to the number of shares of the Company’s common stock underlying the Notes, at an initial strike price of approximately $97.32 per share. The convertible note hedge will expire upon the maturity of the Notes, if not earlier exercised or terminated. The cost of the convertible note hedge was approximately $100.6 million and was accounted for as an equity instrument, which was recorded in additional paid-in capital in the Condensed Consolidated Balance Sheets. The Company recorded a deferred tax asset of $25.8 million at issuance related to the convertible note hedge transaction. The convertible note hedge is expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes. Separately from the convertible note hedge, the Company entered into warrant transactions to sell to the option counterparties warrants to acquire, subject to customary anti-dilution adjustments, up to approximately 5.9 million shares of its common stock in the aggregate at an initial strike price of $141.56 per share. The warrants require net share or net cash settlement upon the Company’s election. The Company received aggregate proceeds of approximately $51.3 million for the issuance of the warrants, which was recorded in additional paid-in capital at issuance in the Condensed Consolidated Balance Sheets. The warrants could separately have a dilutive effect to the Company’s common stock to the extent that the market price per share of its common stock exceeds the strike price of the warrants.

Convertible Senior Notes

Convertible Senior Notes	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes	Debt and Credit Agreement 2019 Revolving Credit Facility On November 15, 2019, the Company entered into an Amended and Restated Credit Agreement (as subsequently amended as discussed below, the “A&R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers, and Wells Fargo Bank, National Association, as administrative agent. The A&R Credit Agreement superseded the Company’s 2016 secured credit facility and provides for (a) a five-year revolving credit facility of $500.0 million (the “Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million (the “Incremental Facility”). In addition, the A&R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. The A&R Credit Agreement has an expiration date of November 15, 2024, upon which date all remaining outstanding borrowings will be due and payable. On September 22, 2020, the parties entered into a first amendment to the A&R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions, as described in Note 10, Convertible Senior Notes , expand the Company’s flexibility to repurchase its common stock and make other restricted payments, and replace the total net leverage covenant with a new secured net leverage covenant that requires the Company to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter. The availability of funds under the Revolving Credit Facility may be subject to reduction in order to maintain compliance with the financial covenants under the A&R Credit Agreement. On March 29, 2023, the parties entered into a second amendment to the A&R Credit Agreement to remove and replace the interest rate benchmark based on the London interbank offered rate (“LIBOR”) and related LIBOR-based mechanics applicable to borrowings under the A&R Credit Agreement with an interest rate benchmark based on the secured overnight financing rate (“SOFR”) as administered by the Federal Reserve Bank of New York (including a customary credit spread adjustment of 0.10% per annum) and related SOFR-based mechanics. The replacement of LIBOR did not, and the Company does not anticipate that it will, materially impact its liquidity or financial position. Following the second amendment to the A&R Credit Agreement, loans under the Revolving Credit Facility bear interest, at the Company’s option, at a rate equal to either (a) the Adjusted Term SOFR (as defined in the A&R Credit Agreement), plus an applicable margin ranging from 1.25% to 2.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the A&R Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50%, and (iii) Adjusted Term SOFR for a one month tenor plus 1.00%, plus an applicable margin ranging from 0.25% to 1.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio. Undrawn commitments under the Revolving Credit Facility are subject to a commitment fee ranging from 0.15% to 0.30% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Revolving Credit Facility. The applicable margin for, and certain other terms of, any term loans under the Incremental Facility will be determined prior to the incurrence of such loans. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty. The A&R Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends, and other distributions. The A&R Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum total secured net leverage ratio (as described above) and maintain a minimum interest coverage ratio. In addition, the A&R Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal, and fees, or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults, and events of bankruptcy. The Company’s obligations under the A&R Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and such subsidiary guarantors’ assets. In connection with entering into the A&R Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a reaffirmation agreement, which amends certain terms of the existing collateral agreement and reaffirms their obligations under the existing guaranty agreement. The Company was in compliance with all covenants as of June 30, 2023. As of June 30, 2023 and December 31, 2022, the Company had $417.7 million and $500.0 million of funds available under the Revolving Credit Facility, respectively. As of June 30, 2023 and December 31, 2022, the Company had no outstanding balance under the Revolving Credit Facility. 0.25% Convertible Senior Notes due 2025 On September 25, 2020, the Company completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. The Company received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes were issued pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted. The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 15, 2025, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ended on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Notes on each such trading day; (iii) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; and (iv) upon the occurrence of specified corporate events, as specified in the Indenture. On or after May 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing conditions. During the three months ended June 30, 2023 and December 31, 2022, none of the conditional conversion features of the Notes were triggered, and therefore, the Notes are not convertible during the third quarter of 2023, commencing on July 1, 2023, and were not convertible during the first quarter of 2023, commencing on January 1, 2023, respectively. Accordingly, the Company classified the Notes as a long-term liability in its Condensed Consolidated Financial Statements as of both June 30, 2023 and December 31, 2022. Whether the Notes will be convertible following the third fiscal quarter of 2023 will depend on the satisfaction of the conversion conditions in the future. Under the original terms of the Indenture, upon conversion, the Company could satisfy its conversion obligation by paying or delivering cash, shares of its common stock, or a combination thereof, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. On December 13, 2021, the Company irrevocably elected to fix its settlement method to a combination of cash and shares of the Company’s common stock with the specified cash amount per $1,000 principal amount of Notes of at least $1,000. As a result, for Notes converted on or after December 13, 2021, a converting noteholder will receive (i) up to $1,000 in cash per $1,000 principal amount of Notes and (ii) cash and/or shares of the Company’s common stock, at the Company’s option for any conversion consideration in excess of $1,000. In addition, the Company continues to have the ability to set the specified cash amount per $1,000 principal amount of Notes above $1,000. The initial conversion rate for the Notes is 10.2751 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $97.32 per share of the Company’s common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that could occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes (or any portion thereof) in connection with such a corporate event or convert its Notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be. If the Company undergoes a fundamental change, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. As of June 30, 2023, none of the criteria for a fundamental change or a conversion rate adjustment had been met. The Company may not redeem the Notes prior to September 20, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on or after September 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all of the outstanding Notes, at least $150.0 million aggregate principal amount of Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for in the Notes. The debt issuance costs associated with the Notes are being amortized to interest expense over the term of the Notes using an effective interest rate of 0.80%. As of June 30, 2023, the remaining life of the Notes and the related issuance cost accretion is approximately 2.2 years. The maximum number of shares issuable upon conversion, including the effect of a fundamental change and subject to other conversion rate adjustments, would be 5.9 million shares. As of June 30, 2023, the if-converted value of the Notes did not exceed the principal amount. The Notes consisted of the following balances reported in the Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Principal amount $ 575,000 $ 575,000 Unamortized debt issuance costs (6,886) (8,429) Convertible senior notes, net $ 568,114 $ 566,571 The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Contractual coupon interest $ 359 $ 359 $ 719 $ 719 Amortization of debt issuance costs $ 772 $ 766 $ 1,543 $ 1,530 Convertible Note Hedge and Warrant Transactions In connection with the issuance of the Notes in September 2020, the Company entered into convertible note hedge and warrant transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”) with respect to the Company’s common stock. The convertible note hedge consists of an option for the Company to purchase up to approximately 5.9 million shares of the Company’s common stock, which is equal to the number of shares of the Company’s common stock underlying the Notes, at an initial strike price of approximately $97.32 per share. The convertible note hedge will expire upon the maturity of the Notes, if not earlier exercised or terminated. The cost of the convertible note hedge was approximately $100.6 million and was accounted for as an equity instrument, which was recorded in additional paid-in capital in the Condensed Consolidated Balance Sheets. The Company recorded a deferred tax asset of $25.8 million at issuance related to the convertible note hedge transaction. The convertible note hedge is expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes. Separately from the convertible note hedge, the Company entered into warrant transactions to sell to the option counterparties warrants to acquire, subject to customary anti-dilution adjustments, up to approximately 5.9 million shares of its common stock in the aggregate at an initial strike price of $141.56 per share. The warrants require net share or net cash settlement upon the Company’s election. The Company received aggregate proceeds of approximately $51.3 million for the issuance of the warrants, which was recorded in additional paid-in capital at issuance in the Condensed Consolidated Balance Sheets. The warrants could separately have a dilutive effect to the Company’s common stock to the extent that the market price per share of its common stock exceeds the strike price of the warrants.

Lessor Leases

Lessor Leases	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Lessor Leases	Lessor Leases Sales-Type Leases The Company enters into multi-year, sales-type lease agreements, with the leases varying in length from one The following table presents the Company’s income recognized from sales-type leases for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Sales-type lease revenues $ 7,856 $ 17,413 $ 13,572 $ 23,918 Cost of sales-type lease revenues (4,380) (8,528) (7,042) (11,606) Selling profit on sales-type lease revenues $ 3,476 $ 8,885 $ 6,530 $ 12,312 The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Net minimum lease payments to be received $ 53,675 $ 50,755 Less: Unearned interest income portion (7,558) (6,345) Net investment in sales-type leases 46,117 44,410 Less: Current portion (1) (11,078) (11,486) Long-term investment in sales-type leases, net $ 35,039 $ 32,924 _________________________________________________ (1) The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets. The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value. The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows: June 30, (In thousands) Remaining six months of 2023 $ 6,956 2024 11,780 2025 9,360 2026 7,727 2027 6,280 Thereafter 11,572 Total future minimum sales-type lease payments 53,675 Present value adjustment (7,558) Total net investment in sales-type leases $ 46,117 Operating Leases The following table represents the Company’s income recognized from operating leases for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Rental income $ 1,870 $ 2,421 $ 4,129 $ 4,893
Lessor Leases	Lessor Leases Sales-Type Leases The Company enters into multi-year, sales-type lease agreements, with the leases varying in length from one The following table presents the Company’s income recognized from sales-type leases for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Sales-type lease revenues $ 7,856 $ 17,413 $ 13,572 $ 23,918 Cost of sales-type lease revenues (4,380) (8,528) (7,042) (11,606) Selling profit on sales-type lease revenues $ 3,476 $ 8,885 $ 6,530 $ 12,312 The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Net minimum lease payments to be received $ 53,675 $ 50,755 Less: Unearned interest income portion (7,558) (6,345) Net investment in sales-type leases 46,117 44,410 Less: Current portion (1) (11,078) (11,486) Long-term investment in sales-type leases, net $ 35,039 $ 32,924 _________________________________________________ (1) The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets. The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value. The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows: June 30, (In thousands) Remaining six months of 2023 $ 6,956 2024 11,780 2025 9,360 2026 7,727 2027 6,280 Thereafter 11,572 Total future minimum sales-type lease payments 53,675 Present value adjustment (7,558) Total net investment in sales-type leases $ 46,117 Operating Leases The following table represents the Company’s income recognized from operating leases for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Rental income $ 1,870 $ 2,421 $ 4,129 $ 4,893

Lessee Leases

Lessee Leases	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Lessee Leases	Lessee Leases The Company has operating leases for office buildings, data centers, office equipment, and vehicles. The Company’s leases have initial terms of one The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Condensed Consolidated Balance Sheets was as follows: June 30, (In thousands) Remaining six months of 2023 $ 6,721 2024 12,388 2025 9,664 2026 8,996 2027 7,340 Thereafter 8,084 Total operating lease payments 53,193 Present value adjustment (6,732) Total operating lease liabilities (1) $ 46,461 _________________________________________________ (1) Amount consists of a current and long-term portion of operating lease liabilities of $11.0 million and $35.5 million, respectively. The current portion of the operating lease liabilities is included in accrued liabilities Operating lease costs were $2.6 million and $4.7 million for the three months ended June 30, 2023 and 2022, respectively, and $5.6 million and $8.8 million for the six months ended June 30, 2023 and 2022, respectively. Short-term lease costs and variable lease costs were not material for the three and six months ended June 30, 2023 and 2022. The Company recorded impairment and abandonment charges to operating lease right-of-use assets of $7.8 million during the six months ended June 30, 2023, and $3.3 million and $5.1 million during the three and six months ended June 30, 2022, respectively, in connection with restructuring activities to reduce its real estate footprint and for optimization of certain leased facilities. The impairment and abandonment charges were recorded to selling, general, and administrative expenses on the Company’s Condensed Consolidated Statements of Operations. Refer to Note 16, Restructuring Expenses, for additional information regarding the Company’s restructuring activities. The following table summarizes supplemental cash flow information related to the Company’s operating leases for the six months ended June 30, 2023 and 2022: Six Months Ended June 30, 2023 2022 (In thousands) Cash paid for amounts included in the measurement of lease liabilities $ 6,725 $ 8,607 Right-of-use assets obtained in exchange for new lease liabilities $ 1,608 $ 10,685 The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of June 30, 2023 and December 31, 2022: June 30, December 31, Weighted-average remaining lease term, years 4.8 5.0 Weighted-average discount rate, % 5.7 % 5.7 %

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Obligations In the ordinary course of business, the Company issues purchase orders based on its current manufacturing needs. As of June 30, 2023, the Company had non-cancelable purchase commitments of $127.1 million, of which $106.9 million are expected to be paid within the year ending December 31, 2023. Ransomware Incident During the six months ended June 30, 2023, the Company did not incur any material expenses related to the previously disclosed ransomware incident. During the three months ended June 30, 2022, the Company incurred $12.5 million of expenses related to the ransomware incident, partially offset by $11.1 million of expected insurance recoveries. Expenses include costs to investigate and remediate the ransomware incident, as well as legal and other professional services, all of which were expensed as incurred. For the three months ended June 30, 2022, the Company included net expenses of $0.2 million in cost of revenues and $1.2 million in selling, general, and administrative expenses in the Company’s Condensed Consolidated Statements of Operations. As of June 30, 2023, the Company has incurred $13.6 million of cumulative expenses related to the ransomware incident since it was detected, partially offset by $11.1 million of insurance recoveries, of which $10.9 million have been received as of June 30, 2023. Legal Proceedings The Company is currently involved in various legal proceedings. A class action lawsuit was filed against the Company, on June 5, 2019, in the Circuit Court of Cook County, Illinois, Chancery Division, captioned Corey Heard, individually and on behalf of all others similarly situated v. Omnicell, Inc., Case No. 2019-CH-06817 (the “Heard Action”). The complaint seeks class certification, monetary damages in the form of statutory damages for willful and/or reckless or, in the alternative, negligent violation of the Illinois Biometric Information Privacy Act (“BIPA”), and certain declaratory, injunctive, and other relief based on causes of action directed to allegations of violation of BIPA by the Company. The complaint was served on the Company on June 13, 2019. On July 31, 2019, the Company filed a motion to stay or consolidate the case with the action Yana Mazya, et al. v. Northwestern Lake Forest Hospital, et al., Case No. 2018-CH-07161, pending in the Circuit Court of Cook County, Illinois, Chancery Division (the “Mazya Action”). The Court subsequently, on October 10, 2019, denied the motion, without prejudice, as being moot in view of the dismissal of the claims against the Company in the Mazya Action. The Company filed a motion to dismiss the complaint in the Heard Action on October 31, 2019. The hearing on the Company’s motion to dismiss was held on September 2, 2020. The Court ruled from the bench and dismissed the complaint without prejudice giving plaintiff leave to file an amended complaint by September 30, 2020. Plaintiff filed an amended complaint on September 30, 2020 and the Company subsequently filed a motion to dismiss the amended complaint on October 28, 2020, which was fully briefed, but the Court had not heard oral argument on the motion. The parties entered into a settlement agreement on January 25, 2022, (the “Settlement Agreement”). On February 1, 2022, the Court granted preliminary approval of the settlement. Following preliminary approval, plaintiff conducted discovery to identify class members and to determine the class size. Pursuant to the terms of the Settlement Agreement, and following class size discovery, the parties participated in non-binding mediation on November 21, 2022. A settlement was reached at the mediation and the parties executed an addendum to the Settlement Agreement (the “Addendum”) reflecting the changes to the original settlement terms. On November 30, 2022, the Court granted preliminary approval of the settlement contemplated by the Settlement Agreement, as amended by the Addendum. The Addendum required Omnicell to make a total settlement payment of $4.3 million. On April 6, 2023, the Court granted final approval of the settlement, including the Addendum, and entered judgment in the matter dismissing all claims against Omnicell with prejudice. The Company made its final required settlement payment installment on or before the April 21, 2023 due date. As required under ASC 450, Contingencies , the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any material accrual for contingent liabilities associated with its current legal proceedings based on its belief that any potential material loss, while reasonably possible, is not probable. Furthermore, any possible range of loss in these matters cannot be reasonably estimated at this time. The Company believes that it has valid defenses with respect to legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of legal proceedings or because of the diversion of management’s attention and the creation of significant expenses, regardless of outcome. The Company is not a party to any legal proceedings that management believes may have a material impact on the Company’s financial position or results of operations.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company generally provides for income taxes in interim periods based on the estimated annual effective tax rate for the year, adjusting for discrete items in the quarter in which they arise. For the six months ended June 30, 2023, the Company recorded a provision for income taxes of $2.6 million by applying its estimated annual effective tax rate of 1.7% to its year-to-date measure of ordinary income and adjusted for $2.7 million of discrete income tax expense primarily from equity compensation. Benefit from income taxes for the six months ended June 30, 2022 was $1.5 million by applying its estimated annual effective tax rate of 24.1% to its year-to-date measure of ordinary income and included a net discrete income tax benefit of $5.3 million, primarily due to a tax benefit from equity compensation. The 2023 annual effective tax rate before discrete items differed from the statutory rate of 21% primarily due to the favorable benefit of the research and development credits and a foreign-derived intangible income (“FDII”) benefit deduction, partially offset by unfavorable impact of the non-deductible compensation and equity charges and Global Intangible Low-Taxed Income (“GILTI”) tax inclusion. The 2022 annual effective tax rate before discrete items differed from the statutory rate of 21% primarily due to the unfavorable impact of state income taxes, non-deductible compensation and equity charges, and GILTI tax inclusion, partially offset by the favorable impact of research and development credits and an FDII deduction. On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was signed into law and introduced a 15% corporate alternative minimum tax for tax years beginning after December 31, 2022 and levies a 1% excise tax on net stock repurchases after December 31, 2022. These provisions did not have an impact on the Company’s provision for income taxes for the six months ended June 30, 2023. As of June 30, 2023 and December 31, 2022, the Company had gross unrecognized tax benefits of $10.0 million and $9.3 million, respectively. The Company recognizes interest and penalties related to uncertain tax positions in interest and other income (expense), net in the Condensed Consolidated Statements of Operations. Accrued interest and penalties are included within other long-term liabilities on the Condensed Consolidated Balance Sheets. As of June 30, 2023 and December 31, 2022, the amount of accrued interest and penalties was $0.3 million and $0.2 million, respectively. The Company files income tax returns in the United States and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examinations by taxing authorities, including major jurisdictions such as the United States, Germany, Italy, France, and the United Kingdom. With few exceptions, as of June 30, 2023, the Company was no longer subject to U.S., state, and foreign tax examinations for years before 2019, 2018, and 2018, respectively. Although the Company believes it has adequately provided for unrecognized tax benefits, the provisions on these positions may change as revised estimates are made or the underlying matters are settled or otherwise resolved. It is not possible at this time to reasonably estimate changes in the unrecognized tax benefits within the next twelve months.

Employee Benefits and Share-Bas

Employee Benefits and Share-Based Compensation	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Employee Benefits and Share-Based Compensation	Employee Benefits and Share-Based Compensation Share-Based Compensation Expense The following table sets forth the total share-based compensation expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Cost of product and service revenues $ 2,268 $ 2,160 $ 4,276 $ 4,404 Research and development 1,697 2,594 3,303 4,858 Selling, general, and administrative 10,124 12,459 20,552 24,159 Total share-based compensation expense $ 14,089 $ 17,213 $ 28,131 $ 33,421 During the three and six months ended June 30, 2023, the Company capitalized approximately $1.1 million and $2.2 million, respectively, of non-cash share-based compensation expense to internal-use and external-use software development costs related to internal labor. The Company did not capitalize any material non-cash share-based compensation expense to inventory during the three and six months ended June 30, 2023 and 2022, or any material non-cash share-based compensation expense to internal-use and external-use software development costs during the three and six months ended June 30, 2022. Employee Stock Purchase Plan (“ESPP”) The following assumptions were used to value shares under the ESPP for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Expected life, years 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected volatility, % 31.7% - 63.9% 28.8% - 45.6% 31.7% - 63.9% 28.8% - 45.6% Risk-free interest rate, % 0.1% - 5.1% 0.1% - 1.5% 0.1% - 5.1% 0.1% - 1.5% Dividend yield, % — % — % — % — % For the six months ended June 30, 2023 and 2022, employees purchased approximately 209,000 and 175,000 shares of common stock, respectively, under the ESPP at a weighted-average price of $46.96 and $66.81, respectively. As of June 30, 2023, the unrecognized compensation cost related to the shares to be purchased under the ESPP was approximately $2.6 million and is expected to be recognized over a weighted-average period of 1.4 years. Stock Options The following assumptions were used to value stock options granted pursuant to the Company’s 2009 Equity Incentive Plan, as amended, (the “2009 Plan”) for the six months ended June 30, 2023. There were no stock options granted during the three months ended June 30, 2023, and the three and six months ended June 30, 2022. Six Months Ended June 30, 2023 Expected life, years 3.2 Expected volatility, % 44.8 % Risk-free interest rate, % 3.7 % Estimated forfeiture rate, % 10.0 % Dividend yield, % — % The following table summarizes the stock option activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average Weighted-Average Aggregate (In thousands, except per share data) Outstanding at December 31, 2022 2,434 $ 68.65 6.1 $ 7,887 Granted 200 55.60 Exercised (130) 41.54 Expired (72) 77.54 Forfeited (119) 80.50 Outstanding at June 30, 2023 2,313 $ 68.16 5.3 $ 26,912 Exercisable at June 30, 2023 1,863 $ 66.78 5.1 $ 23,098 Vested and expected to vest at June 30, 2023 and thereafter 2,282 $ 68.10 5.3 $ 26,591 The weighted-average fair value per share of options granted during the six months ended June 30, 2023 was $19.48. The intrinsic value of options exercised during the three months ended June 30, 2023 and 2022 was $1.3 million and $2.8 million, respectively, and during the six months ended June 30, 2023 and 2022 was $2.6 million and $15.5 million, respectively. As of June 30, 2023, total unrecognized compensation cost related to unvested stock options was $12.6 million, which is expected to be recognized over a weighted-average vesting period of 1.1 years. Restricted Stock Units (“RSUs”) The following table summarizes the RSU activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average Weighted-Average Aggregate (In thousands, except per share data) Outstanding at December 31, 2022 1,117 $ 115.75 1.6 $ 56,297 Granted (Awarded) 244 67.10 Vested (Released) (129) 124.31 Forfeited (237) 114.73 Outstanding and unvested at June 30, 2023 995 $ 103.00 1.5 $ 73,319 As of June 30, 2023, total unrecognized compensation cost related to RSUs was $95.4 million, which is expected to be recognized over the remaining weighted-average vesting period of 2.9 years. Restricted Stock Awards (“RSAs”) The following table summarizes the RSA activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average (In thousands, except per share data) Outstanding at December 31, 2022 13 $ 109.39 Granted (Awarded) 21 72.02 Vested (Released) (13) 109.39 Outstanding and unvested at June 30, 2023 21 $ 72.02 As of June 30, 2023, total unrecognized compensation cost related to RSAs was $1.2 million, which is expected to be recognized over the remaining weighted-average vesting period of 0.9 years. Performance-Based Stock Unit Awards (“PSUs”) The following table summarizes the PSU activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average (In thousands, except per share data) Outstanding at December 31, 2022 135 $ 147.42 Granted 65 122.29 Vested (30) 139.58 Forfeited (63) 153.89 Outstanding and unvested at June 30, 2023 107 $ 130.59 As of June 30, 2023, total unrecognized compensation cost related to PSUs was approximately $8.7 million, which is expected to be recognized over the remaining weighted-average vesting period of 1.6 years. Summary of Shares Reserved for Future Issuance under Equity Incentive Plans The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of June 30, 2023: Number of Shares (In thousands) Stock options outstanding 2,313 Non-vested restricted stock awards 1,123 Shares authorized for future issuance 2,932 ESPP shares available for future issuance 3,394 Total shares reserved for future issuance 9,762 Stock Repurchase Programs On August 2, 2016, the Company’s Board of Directors (the “Board”) authorized a stock repurchase program providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2016 Repurchase Program”). The 2016 Repurchase Program is in addition to the stock repurchase program approved by the Board on November 4, 2014 providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2014 Repurchase Program”). During the first quarter of 2022, the 2014 Repurchase Program was completed, and as of June 30, 2023, the maximum dollar value of shares that may yet be purchased under the 2016 Repurchase Program was $2.7 million. The 2016 Repurchase Program does not obligate the Company to repurchase any specific number of shares, and the Company may terminate or suspend the 2016 Repurchase Program at any time. During the six months ended June 30, 2022, the Company repurchased approximately 389,300 shares of its common stock under the repurchase programs at an average price of $134.11 per share for an aggregate purchase price of approximately $52.2 million. During the three and six months ended June 30, 2023 and the three months ended June 30, 2022, the Company did not repurchase any of its outstanding common stock under the 2016 Repurchase Program.

Restructuring Expenses

Restructuring Expenses	6 Months Ended
	Jun. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring Expenses	Restructuring Expenses During the first quarter of 2022, the Company initiated certain domestic and international restructuring initiatives, in order to enhance and streamline certain engineering functions for its domestic operations, and to realign its international sales organization to better serve its customers in various international markets. During the six months ended June 30, 2022, the Company incurred $3.5 million of employee severance costs and related expenses in connection with this restructuring plan. As of June 30, 2023, there was no material unpaid balance related to this restructuring plan. On November 23, 2022, the Company committed to a plan to reduce the Company’s headcount (the “Plan”), as part of the Company’s expense containment efforts being implemented due to ongoing macroeconomic headwinds. During the first quarter of 2023, as a result of continued exploration of expense containment measures, the Company committed to further reduce its headcount across many of its functions, and also committed to reduce its real estate footprint to align with its broader hybrid work strategy and in an effort to further reduce costs. During the three and six months ended June 30, 2023, the Company incurred $0.7 million and $6.0 million, respectively, of employee severance costs and related expenses in connection with the Plan. As of June 30, 2023, the Company has incurred $23.5 million of cumulative restructuring expense related to employee severance costs and related expenses since the inception of the Plan. As of June 30, 2023 and December 31, 2022, the unpaid balance related to the Plan was $2.8 million and $18.2 million, respectively. Refer to Note 12, Lessee Leases , for information regarding the Company’s restructuring activities for the reduction of its real estate footprint and optimization of certain leased facilities. The following table summarizes the total employee-related restructuring expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Cost of product and service revenues $ 238 $ — $ 382 $ 156 Research and development 7 — 492 1,594 Selling, general, and administrative 476 — 5,161 1,777 Total restructuring expense $ 721 $ — $ 6,035 $ 3,527

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net income	$ 3,451	$ (15,000)	$ 9,069	$ 8,213	$ (11,549)	$ 17,282

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, consisting of normal recurring adjustments and accruals, necessary to present fairly the financial position of the Company as of June 30, 2023 and December 31, 2022, the results of operations and comprehensive income (loss) for the three and six months ended June 30, 2023 and 2022, and cash flows for the six months ended June 30, 2023 and 2022. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) have been condensed or omitted in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and accompanying Notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 1, 2023, except as discussed in the section entitled “Recently Adopted Authoritative Guidance” below. The Company’s results of operations and comprehensive income (loss) for the three and six months ended June 30, 2023, and cash flows for the six months ended June 30, 2023 are not necessarily indicative of results that may be expected for the year ending December 31, 2023, or for any future period.
Principles of Consolidation	The Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Condensed Consolidated Financial Statements and accompanying Notes. These estimates are based on historical experience and various other assumptions that management believes to be reasonable. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. As of June 30, 2023, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities.
Segment Reporting	The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company’s Chief Operating Decision Maker (“CODM”) is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.
Recently Adopted and Issued Authoritative Guidance	Recently Adopted Authoritative Guidance In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . The update addresses diversity in practice by requiring that an acquirer recognize and measure contract assets and liabilities acquired in a business combination in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The Company adopted ASU 2021-08 beginning January 1, 2023 and will apply the guidance prospectively to acquisitions occurring on or after the adoption date. Recently Issued Authoritative Guidance There was no recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Condensed Consolidated Financial Statements through the reporting date.
Revenue Recognition	The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories: Connected devices, software licenses, and other. Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements. Solutions in this category include, but are not limited to, XT Series automated dispensing systems and products related to the Central Pharmacy Dispensing Service and IV Compounding Service. Consumables. Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards, which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, are designed to improve patient engagement and adherence to prescriptions. Technical services. Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements. Advanced Services. Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth ® , Specialty Pharmacy Services, 340B solutions, Inventory Optimization Service, other software solutions, and services related to the Central Pharmacy Dispensing Service and IV Compounding Service. The following table summarizes revenue recognition for each revenue category: Revenue Category Timing of Revenue Recognition Income Statement Classification Connected devices, software licenses, and other Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer Product Consumables Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer Product Technical services Over time, as services are provided, typically ratably over the service term Service Advanced Services Over time, as services are provided Service
Fair Value Hierarchy	The Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company’s credit facility is classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company’s convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jun. 30, 2023
Revenue Recognition [Abstract]
Summary of Revenue Recognition for Revenue Categories	The following table summarizes revenue recognition for each revenue category: Revenue Category Timing of Revenue Recognition Income Statement Classification Connected devices, software licenses, and other Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer Product Consumables Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer Product Technical services Over time, as services are provided, typically ratably over the service term Service Advanced Services Over time, as services are provided Service
Disaggregation of Revenues by Revenue Type	The following table summarizes the Company’s revenues disaggregated by revenue type for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Connected devices, software licenses, and other $ 167,475 $ 215,632 $ 332,622 $ 423,710 Consumables 20,961 18,174 41,529 35,971 Technical services 57,191 53,303 110,548 102,472 Advanced Services 53,346 44,277 104,903 88,061 Total revenues $ 298,973 $ 331,386 $ 589,602 $ 650,214
Disaggregation of Revenues by Geographical Location	The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) United States $ 257,202 $ 294,937 $ 513,145 $ 582,514 Rest of world (1) 41,771 36,449 76,457 67,700 Total revenues $ 298,973 $ 331,386 $ 589,602 $ 650,214 _________________________________________________ (1) No individual country represented more than 10% of total revenues.
Contract Asset and Liabilities	The following table reflects the Company’s contract assets and contract liabilities: June 30, December 31, (In thousands) Short-term unbilled receivables, net (1) $ 22,111 $ 25,763 Long-term unbilled receivables, net (2) 15,132 14,744 Total contract assets $ 37,243 $ 40,507 Short-term deferred revenues, net $ 124,602 $ 118,947 Long-term deferred revenues 48,750 37,385 Total contract liabilities $ 173,352 $ 156,332 _________________________________________________ (1) Included in accounts receivable and unbilled receivables in the Condensed Consolidated Balance Sheets.

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Basic and Diluted Net Income Per Share	The basic and diluted net income (loss) per share calculations for the three and six months ended June 30, 2023 and 2022 were as follows: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands, except per share data) Net income (loss) $ 3,451 $ 9,069 $ (11,549) $ 17,282 Weighted-average shares outstanding – basic 45,125 44,219 45,007 44,234 Effect of dilutive securities from stock award plans 347 1,142 — 1,421 Effect of convertible senior notes — 899 — 1,466 Weighted-average shares outstanding – diluted 45,472 46,260 45,007 47,121 Net income (loss) per share – basic $ 0.08 $ 0.21 $ (0.26) $ 0.39 Net income (loss) per share – diluted $ 0.08 $ 0.20 $ (0.26) $ 0.37 Anti-dilutive weighted-average shares related to stock award plans 2,512 865 3,530 473 Anti-dilutive weighted-average shares related to convertible senior notes and warrants 11,816 5,908 11,816 5,908

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance sheet details as of June 30, 2023 and December 31, 2022 are presented in the tables below: June 30, December 31, (In thousands) Inventories: Raw materials $ 62,757 $ 75,854 Work in process 1,331 9,280 Finished goods 66,489 62,415 Total inventories $ 130,577 $ 147,549 Other current assets: Funds held for customers, including restricted cash (1) $ 34,429 $ 56,703 Net investment in sales-type leases, current portion 11,078 11,486 Prepaid income taxes 63 1,702 Other current assets 8,337 7,471 Total other current assets $ 53,907 $ 77,362 Other long-term assets: External-use software development costs, net $ 73,125 $ 80,760 Unbilled receivables, net 15,132 14,744 Deferred debt issuance costs 1,510 2,058 Other long-term assets 7,024 7,455 Total other long-term assets $ 96,791 $ 105,017 Accrued liabilities: Operating lease liabilities, current portion $ 10,951 $ 10,761 Customer fund liabilities 34,429 56,703 Advance payments from customers 11,547 11,556 Rebate liabilities 46,680 42,802 Group purchasing organization fees 5,428 7,723 Taxes payable 12,337 9,642 Other accrued liabilities 24,516 33,468 Total accrued liabilities $ 145,888 $ 172,655 _________________________________________________ (1) Includes restricted cash of $18.2 million and $22.5 million as of June 30, 2023 and December 31, 2022, respectively.
Schedule of Accumulated Other Comprehensive Income (Loss)	The following table summarizes the changes in accumulated balances of other comprehensive income (loss), which consisted of foreign currency translation adjustments, for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Beginning balance $ (15,608) $ (10,962) $ (17,087) $ (8,407) Other comprehensive income (loss) 1,432 (6,410) 2,911 (8,965) Ending balance $ (14,176) $ (17,372) $ (14,176) $ (17,372)

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Balances	The following table represents the property and equipment balances as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Equipment $ 97,048 $ 91,391 Furniture and fixtures 4,915 5,154 Leasehold improvements 18,841 19,510 Purchased software and internal-use software development costs 93,396 76,327 Construction in progress 27,564 28,223 Property and equipment, gross 241,764 220,605 Accumulated depreciation and amortization (138,552) (126,644) Total property and equipment, net $ 103,212 $ 93,961
Summary of Geographic Information for Property and Equipment, Net	The following table summarizes the geographic information for property and equipment, net, as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) United States $ 99,383 $ 89,989 Rest of world (1) 3,829 3,972 Total property and equipment, net $ 103,212 $ 93,961 _________________________________________________ (1) No individual country represented more than 10% of total property and equipment, net.

External-Use Software Develop_2

External-Use Software Development Costs (Tables)	6 Months Ended
	Jun. 30, 2023
Research and Development [Abstract]
Schedule of Capitalized Computer Software	The carrying amounts of external-use software development costs as of June 30, 2023 and December 31, 2022 were as follows: June 30, December 31, (In thousands) Gross carrying amount $ 232,199 $ 225,004 Accumulated amortization (159,074) (144,244) External-use software development costs, net (1) $ 73,125 $ 80,760 _________________________________________________ (1) Included in other long-term assets in the Condensed Consolidated Balance Sheets.
Schedule of Future Amortization Expenses For Capitalized Software Development Costs	The estimated future amortization expenses for external-use software development costs were as follows: June 30, (In thousands) Remaining six months of 2023 $ 14,090 2024 24,219 2025 16,843 2026 11,304 2027 5,349 Thereafter 1,320 Total $ 73,125

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	The following table represents changes in the carrying amount of goodwill: (In thousands) Balance as of December 31, 2022 $ 734,274 Foreign currency exchange rate fluctuations 1,249 Balance as of June 30, 2023 $ 735,523
Carrying Amounts and Useful Lives of Intangible Assets	The carrying amounts and useful lives of intangible assets as of June 30, 2023 and December 31, 2022 were as follows: June 30, 2023 Gross carrying Accumulated Foreign currency exchange Net carrying Useful life (In thousands, except for years) Customer relationships $ 311,089 $ (109,038) $ (1,350) $ 200,701 4 - 30 Acquired technology 92,066 (69,641) — 22,425 4 - 20 Backlog 1,800 (1,350) — 450 2 Trade names 9,200 (7,156) — 2,044 5 - 12 Patents 2,430 (1,393) — 1,037 2 - 20 Non-compete agreements 600 (550) — 50 3 Total intangibles assets, net $ 417,185 $ (189,128) $ (1,350) $ 226,707 December 31, 2022 Gross carrying Accumulated Foreign currency exchange Net carrying Useful life (In thousands, except for years) Customer relationships $ 311,089 $ (99,177) $ (1,514) $ 210,398 4 - 30 Acquired technology 92,066 (64,299) — 27,767 4 - 20 Backlog 1,800 (900) — 900 2 Trade names 9,200 (6,633) — 2,567 5 - 12 Patents 2,430 (1,306) — 1,124 2 - 20 Non-compete agreements 600 (450) — 150 3 Total intangibles assets, net $ 417,185 $ (172,765) $ (1,514) $ 242,906
Estimated Future Amortization Expense for Intangible Assets	The estimated future amortization expenses for amortizable intangible assets were as follows: June 30, (In thousands) Remaining six months of 2023 $ 15,194 2024 23,086 2025 21,062 2026 18,077 2027 16,800 Thereafter 132,488 Total $ 226,707

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Convertible Debt Balances	The Notes consisted of the following balances reported in the Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Principal amount $ 575,000 $ 575,000 Unamortized debt issuance costs (6,886) (8,429) Convertible senior notes, net $ 568,114 $ 566,571
Summary of Components of Interest Expense	The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Contractual coupon interest $ 359 $ 359 $ 719 $ 719 Amortization of debt issuance costs $ 772 $ 766 $ 1,543 $ 1,530

Lessor Leases (Tables)

Lessor Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Income Recognized from Sales-Type Leases	The following table presents the Company’s income recognized from sales-type leases for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Sales-type lease revenues $ 7,856 $ 17,413 $ 13,572 $ 23,918 Cost of sales-type lease revenues (4,380) (8,528) (7,042) (11,606) Selling profit on sales-type lease revenues $ 3,476 $ 8,885 $ 6,530 $ 12,312
Components of Sales-Type Lease Receivables	The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at June 30, 2023 and December 31, 2022: June 30, December 31, (In thousands) Net minimum lease payments to be received $ 53,675 $ 50,755 Less: Unearned interest income portion (7,558) (6,345) Net investment in sales-type leases 46,117 44,410 Less: Current portion (1) (11,078) (11,486) Long-term investment in sales-type leases, net $ 35,039 $ 32,924 _________________________________________________ (1) The current portion of the net investment in sales-type leases is included in other current assets in the Condensed Consolidated Balance Sheets.
Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases	The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Condensed Consolidated Balance Sheets was as follows: June 30, (In thousands) Remaining six months of 2023 $ 6,956 2024 11,780 2025 9,360 2026 7,727 2027 6,280 Thereafter 11,572 Total future minimum sales-type lease payments 53,675 Present value adjustment (7,558) Total net investment in sales-type leases $ 46,117
Income Recognized from Operating Leases	The following table represents the Company’s income recognized from operating leases for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Rental income $ 1,870 $ 2,421 $ 4,129 $ 4,893

Lessee Leases (Tables)

Lessee Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities	The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Condensed Consolidated Balance Sheets was as follows: June 30, (In thousands) Remaining six months of 2023 $ 6,721 2024 12,388 2025 9,664 2026 8,996 2027 7,340 Thereafter 8,084 Total operating lease payments 53,193 Present value adjustment (6,732) Total operating lease liabilities (1) $ 46,461 _________________________________________________ (1) Amount consists of a current and long-term portion of operating lease liabilities of $11.0 million and $35.5 million, respectively. The current portion of the operating lease liabilities is included in accrued liabilities
Summary of Supplemental Cash Flow Information and Weighted-Average Remaining Lease Term and Discount Rate	The following table summarizes supplemental cash flow information related to the Company’s operating leases for the six months ended June 30, 2023 and 2022: Six Months Ended June 30, 2023 2022 (In thousands) Cash paid for amounts included in the measurement of lease liabilities $ 6,725 $ 8,607 Right-of-use assets obtained in exchange for new lease liabilities $ 1,608 $ 10,685 The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of June 30, 2023 and December 31, 2022: June 30, December 31, Weighted-average remaining lease term, years 4.8 5.0 Weighted-average discount rate, % 5.7 % 5.7 %

Employee Benefits and Share-B_2

Employee Benefits and Share-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation Expense	The following table sets forth the total share-based compensation expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Cost of product and service revenues $ 2,268 $ 2,160 $ 4,276 $ 4,404 Research and development 1,697 2,594 3,303 4,858 Selling, general, and administrative 10,124 12,459 20,552 24,159 Total share-based compensation expense $ 14,089 $ 17,213 $ 28,131 $ 33,421
Assumptions Used to Value ESPP Shares	The following assumptions were used to value shares under the ESPP for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 Expected life, years 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected volatility, % 31.7% - 63.9% 28.8% - 45.6% 31.7% - 63.9% 28.8% - 45.6% Risk-free interest rate, % 0.1% - 5.1% 0.1% - 1.5% 0.1% - 5.1% 0.1% - 1.5% Dividend yield, % — % — % — % — %
Assumptions Used to Value Stock Options Granted	The following assumptions were used to value stock options granted pursuant to the Company’s 2009 Equity Incentive Plan, as amended, (the “2009 Plan”) for the six months ended June 30, 2023. There were no stock options granted during the three months ended June 30, 2023, and the three and six months ended June 30, 2022. Six Months Ended June 30, 2023 Expected life, years 3.2 Expected volatility, % 44.8 % Risk-free interest rate, % 3.7 % Estimated forfeiture rate, % 10.0 % Dividend yield, % — %
Summary of Share Option Activity	The following table summarizes the stock option activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average Weighted-Average Aggregate (In thousands, except per share data) Outstanding at December 31, 2022 2,434 $ 68.65 6.1 $ 7,887 Granted 200 55.60 Exercised (130) 41.54 Expired (72) 77.54 Forfeited (119) 80.50 Outstanding at June 30, 2023 2,313 $ 68.16 5.3 $ 26,912 Exercisable at June 30, 2023 1,863 $ 66.78 5.1 $ 23,098 Vested and expected to vest at June 30, 2023 and thereafter 2,282 $ 68.10 5.3 $ 26,591
Summary of Restricted Stock Unit Activity	The following table summarizes the RSU activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average Weighted-Average Aggregate (In thousands, except per share data) Outstanding at December 31, 2022 1,117 $ 115.75 1.6 $ 56,297 Granted (Awarded) 244 67.10 Vested (Released) (129) 124.31 Forfeited (237) 114.73 Outstanding and unvested at June 30, 2023 995 $ 103.00 1.5 $ 73,319
Summary of Restricted Stock Awards Activity	The following table summarizes the RSA activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average (In thousands, except per share data) Outstanding at December 31, 2022 13 $ 109.39 Granted (Awarded) 21 72.02 Vested (Released) (13) 109.39 Outstanding and unvested at June 30, 2023 21 $ 72.02
Summary of Performance-Based Restricted Stock Activity	The following table summarizes the PSU activity under the 2009 Plan during the six months ended June 30, 2023: Number of Weighted-Average (In thousands, except per share data) Outstanding at December 31, 2022 135 $ 147.42 Granted 65 122.29 Vested (30) 139.58 Forfeited (63) 153.89 Outstanding and unvested at June 30, 2023 107 $ 130.59
Ordinary Shares Reserved for Future Issuance Under Equity Incentive Plans	The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of June 30, 2023: Number of Shares (In thousands) Stock options outstanding 2,313 Non-vested restricted stock awards 1,123 Shares authorized for future issuance 2,932 ESPP shares available for future issuance 3,394 Total shares reserved for future issuance 9,762

Restructuring Expenses (Tables)

Restructuring Expenses (Tables)	6 Months Ended
	Jun. 30, 2023
Restructuring and Related Activities [Abstract]
Total Restructuring Expense Recognized in the Condensed Consolidated Statements of Operations	The following table summarizes the total employee-related restructuring expense recognized in the Company’s Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (In thousands) Cost of product and service revenues $ 238 $ — $ 382 $ 156 Research and development 7 — 492 1,594 Selling, general, and administrative 476 — 5,161 1,777 Total restructuring expense $ 721 $ — $ 6,035 $ 3,527

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies - Narrative (Details)	6 Months Ended
	Jun. 30, 2023 segment
Accounting Policies [Abstract]
Number of operating segments	1
Number of reportable segments	1

Revenues - Narrative (Details)

Revenues - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Revenue Recognition [Abstract]
Fees to GPOs	$ 2,800	$ 4,000	$ 5,900	$ 8,500
Short-term deferred revenues, net	124,602		124,602		$ 118,947
Deferred cost of sales	13,600		13,600		15,800
Deferred revenues recognized	30,600		86,100
Short-term deferred revenues, gross					134,700
Long-term deferred revenues	48,750		$ 48,750		$ 37,385
Deferred revenue, period			10 years
Remaining performance obligation	$ 288,700		$ 288,700

Revenues - Disaggregation of Re

Revenues - Disaggregation of Revenues by Revenue Type (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue from External Customer [Line Items]
Revenues	$ 298,973	$ 331,386	$ 589,602	$ 650,214
Connected devices, software licenses, and other
Revenue from External Customer [Line Items]
Revenues	167,475	215,632	332,622	423,710
Consumables
Revenue from External Customer [Line Items]
Revenues	20,961	18,174	41,529	35,971
Technical services
Revenue from External Customer [Line Items]
Revenues	57,191	53,303	110,548	102,472
Advanced Services
Revenue from External Customer [Line Items]
Revenues	$ 53,346	$ 44,277	$ 104,903	$ 88,061

Revenues - Disaggregation of _2

Revenues - Disaggregation of Revenues by Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue from External Customer [Line Items]
Revenues	$ 298,973	$ 331,386	$ 589,602	$ 650,214
United States
Revenue from External Customer [Line Items]
Revenues	257,202	294,937	513,145	582,514
Rest of world
Revenue from External Customer [Line Items]
Revenues	$ 41,771	$ 36,449	$ 76,457	$ 67,700

Revenues - Contract Asset and L

Revenues - Contract Asset and Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Revenue Recognition [Abstract]
Short-term unbilled receivables, net	$ 22,111	$ 25,763
Long-term unbilled receivables, net	15,132	14,744
Total contract assets	37,243	40,507
Short-term deferred revenues, net	124,602	118,947
Long-term deferred revenues	48,750	37,385
Total contract liabilities	$ 173,352	$ 156,332

Net Income (Loss) Per Share (De

Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income (loss)	$ 3,451	$ (15,000)	$ 9,069	$ 8,213	$ (11,549)	$ 17,282
Weighted-average shares outstanding – basic (in shares)	45,125		44,219		45,007	44,234
Weighted-average shares outstanding — diluted (in shares)	45,472		46,260		45,007	47,121
Net income (loss) per share – basic (in dollars per share)	$ 0.08		$ 0.21		$ (0.26)	$ 0.39
Net income (loss) per share – diluted (in dollars per share)	$ 0.08		$ 0.20		$ (0.26)	$ 0.37
Stock Award Plans
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities (in shares)	347		1,142		0	1,421
Anti-dilutive weighted-average shares (in shares)	2,512		865		3,530	473
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities (in shares)	0		899		0	1,466
Convertible Senior Notes and Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive weighted-average shares (in shares)	11,816		5,908		11,816	5,908

Cash and Cash Equivalents and_2

Cash and Cash Equivalents and Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Jun. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 399,464	$ 330,362	$ 244,953
Cash equivalents	382,100	301,000
Convertible Senior Notes | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of long-term debt	581,600	501,400
Long-term debt	$ 568,114	$ 566,571

Balance Sheet Components - Bala

Balance Sheet Components - Balance Sheet Components (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Inventories:
Raw materials	$ 62,757	$ 75,854
Work in process	1,331	9,280
Finished goods	66,489	62,415
Total inventories	$ 130,577	$ 147,549
Other current assets:
Restricted Cash, Statement of Financial Position [Extensible Enumeration]	Total other current assets	Total other current assets
Funds held for customers, including restricted cash	$ 34,429	$ 56,703
Net investment in sales-type leases, current portion	11,078	11,486
Prepaid income taxes	63	1,702
Other current assets	8,337	7,471
Total other current assets	53,907	77,362
Other long-term assets:
External-use software development costs, net	73,125	80,760
Unbilled receivables, net	15,132	14,744
Deferred debt issuance costs	1,510	2,058
Other long-term assets	7,024	7,455
Total other long-term assets	$ 96,791	$ 105,017
Accrued liabilities:
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Total accrued liabilities	Total accrued liabilities
Operating lease liabilities, current portion	$ 10,951	$ 10,761
Customer fund liabilities	34,429	56,703
Advance payments from customers	11,547	11,556
Rebate liabilities	46,680	42,802
Group purchasing organization fees	5,428	7,723
Taxes payable	12,337	9,642
Other accrued liabilities	24,516	33,468
Total accrued liabilities	145,888	172,655
Restricted cash	$ 18,200	$ 22,500

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	$ 1,142,541	$ 1,130,137	$ 1,074,741	$ 1,146,689	$ 1,130,137	$ 1,146,689
Other comprehensive income (loss)	1,432	1,479	(6,410)	(2,555)	2,911	(8,965)
Balance at end of period	1,163,565	1,142,541	1,092,637	1,074,741	1,163,565	1,092,637
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period	(15,608)	(17,087)	(10,962)	(8,407)	(17,087)	(8,407)
Other comprehensive income (loss)	1,432	1,479	(6,410)	(2,555)
Balance at end of period	$ (14,176)	$ (15,608)	$ (17,372)	$ (10,962)	$ (14,176)	$ (17,372)

Property and Equipment - Proper

Property and Equipment - Property, Plant and Equipment Balances (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 241,764	$ 220,605
Accumulated depreciation and amortization	(138,552)	(126,644)
Total property and equipment, net	103,212	93,961
Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	97,048	91,391
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,915	5,154
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	18,841	19,510
Purchased software and internal-use software development costs
Property, Plant and Equipment [Line Items]
Property and equipment, gross	93,396	76,327
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 27,564	$ 28,223

Property and Equipment - Narrat

Property and Equipment - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 6.6	$ 5.6	$ 12.9	$ 10.9

Property and Equipment - Summar

Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 103,212	$ 93,961
United States
Property, Plant and Equipment [Line Items]
Property and equipment, net	99,383	89,989
Rest of world
Property, Plant and Equipment [Line Items]
Property and equipment, net	$ 3,829	$ 3,972

External-Use Software Develop_3

External-Use Software Development Costs - Schedule of Capitalized Computer Software (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Research and Development [Abstract]
Capitalized Computer Software, Gross	$ 232,199	$ 225,004
Capitalized Computer Software, Accumulated Amortization	(159,074)	(144,244)
Capitalized software development costs for external use, net	$ 73,125	$ 80,760

External-Use Software Develop_4

External-Use Software Development Costs - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Research and Development [Abstract]
Amortization of capitalized software development costs	$ 7.4	$ 7.5	$ 14.8	$ 14.2

External-Use Software Develop_5

External-Use Software Development Costs - Schedule of Future Amortization Expenses For Capitalized Software Development Costs (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Research and Development [Abstract]
Remaining six months of 2023	$ 14,090
2024	24,219
2025	16,843
2026	11,304
2027	5,349
Thereafter	1,320
Capitalized software development costs for external use, net	$ 73,125	$ 80,760

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Changes in Carrying Amount of Goodwill (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Goodwill [Roll Forward]
Balance at beginning of period	$ 734,274
Foreign currency exchange rate fluctuations	1,249
Balance at end of period	$ 735,523

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 417,185	$ 417,185
Accumulated amortization	(189,128)	(172,765)
Foreign currency exchange rate fluctuations	(1,350)	(1,514)
Net carrying amount	226,707	242,906
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	311,089	311,089
Accumulated amortization	(109,038)	(99,177)
Foreign currency exchange rate fluctuations	(1,350)	(1,514)
Net carrying amount	$ 200,701	$ 210,398
Customer relationships | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	4 years	4 years
Customer relationships | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	30 years	30 years
Acquired technology
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 92,066	$ 92,066
Accumulated amortization	(69,641)	(64,299)
Foreign currency exchange rate fluctuations	0	0
Net carrying amount	$ 22,425	$ 27,767
Acquired technology | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	4 years	4 years
Acquired technology | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	20 years	20 years
Backlog
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 1,800	$ 1,800
Accumulated amortization	(1,350)	(900)
Foreign currency exchange rate fluctuations	0	0
Net carrying amount	$ 450	$ 900
Useful life	2 years	2 years
Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 9,200	$ 9,200
Accumulated amortization	(7,156)	(6,633)
Foreign currency exchange rate fluctuations	0	0
Net carrying amount	$ 2,044	$ 2,567
Trade names | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	5 years	5 years
Trade names | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	12 years	12 years
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 2,430	$ 2,430
Accumulated amortization	(1,393)	(1,306)
Foreign currency exchange rate fluctuations	0	0
Net carrying amount	$ 1,037	$ 1,124
Patents | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	2 years	2 years
Patents | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	20 years	20 years
Non-compete agreements
Acquired Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 600	$ 600
Accumulated amortization	(550)	(450)
Foreign currency exchange rate fluctuations	0	0
Net carrying amount	$ 50	$ 150
Useful life	3 years	3 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of intangible assets	$ 8.1	$ 8.9	$ 16.4	$ 18

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Future Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining six months of 2023	$ 15,194
2024	23,086
2025	21,062
2026	18,077
2027	16,800
Thereafter	132,488
Net carrying amount	$ 226,707	$ 242,906

Debt and Credit Agreement (Deta

Debt and Credit Agreement (Details) - Line of Credit	Mar. 29, 2023	Nov. 15, 2019 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Sep. 22, 2020
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Minimum
Debt Instrument [Line Items]
Commitment fee rate on undrawn commitments	0.15%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Maximum
Debt Instrument [Line Items]
Commitment fee rate on undrawn commitments	0.30%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Spread on variable interest rate	0.10%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Applicable Margin | Minimum
Debt Instrument [Line Items]
Spread on variable interest rate	1.25%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Applicable Margin | Maximum
Debt Instrument [Line Items]
Spread on variable interest rate	2%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Federal Funds
Debt Instrument [Line Items]
Spread on variable interest rate	0.50%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | One Month Adjusted Term Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Spread on variable interest rate	1%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | One Month Secured Overnight Financing Rate (SOFR) Applicable Margin | Minimum
Debt Instrument [Line Items]
Spread on variable interest rate	0.25%
Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | One Month Secured Overnight Financing Rate (SOFR) Applicable Margin | Maximum
Debt Instrument [Line Items]
Spread on variable interest rate	1%
Revolving Credit Facility
Debt Instrument [Line Items]
Long-term line of credit			$ 0	$ 0
Revolving Credit Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank
Debt Instrument [Line Items]
Term of debt instrument		5 years
Maximum borrowing capacity		$ 500,000,000
Remaining borrowing capacity			$ 417,700,000	$ 500,000,000
Revolving Credit Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Calendar Quarters Up To and Including March 31, 2021
Debt Instrument [Line Items]
Maximum secured net leverage ratio					3.50
Revolving Credit Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Calendar Quarters After March 31, 2021
Debt Instrument [Line Items]
Maximum secured net leverage ratio					3
Incremental Loan Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank
Debt Instrument [Line Items]
Maximum borrowing capacity		250,000,000
Letter of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank
Debt Instrument [Line Items]
Maximum borrowing capacity		15,000,000
Swing Line Loan | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 25,000,000

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details)		6 Months Ended
	Sep. 25, 2020 USD ($) day $ / shares shares	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Purchase of convertible note hedge	$ 100,600,000
Proceeds from sale of warrants	51,300,000
Convertible Note Hedge
Debt Instrument [Line Items]
Deferred tax asset related to the convertible note hedge transaction	$ 25,800,000
Convertible Note Hedge Rights
Debt Instrument [Line Items]
Options and warrants to purchase shares (in shares) | shares	5,900,000
Strike price (in dollars per share) | $ / shares	$ 97.32
Warrants
Debt Instrument [Line Items]
Options and warrants to purchase shares (in shares) | shares	5,900,000
Strike price (in dollars per share) | $ / shares	$ 141.56
Convertible Senior Notes
Debt Instrument [Line Items]
Debt instrument, convertible, principal amount of notes, minimum		$ 1,000
Debt instrument, convertible, maximum cash		1,000
Debt instrument, convertible, consideration in excess, amount		1,000
Convertible Senior Notes | Convertible Debt
Debt Instrument [Line Items]
Interest rate	0.25%
Principal amount	$ 575,000,000	$ 575,000,000	$ 575,000,000
Additional principal amount subject to purchasers' option	75,000,000
Proceeds from issuance of convertible senior notes, net of issuance costs	559,700,000
Debt issuance costs incurred and capitalized	$ 15,300,000
Conversion ratio	0.0102751
Conversion price (in dollars per share) | $ / shares	$ 97.32
Repurchase price as a percent of principal amount	100%
Aggregate principal amount of Notes that must be outstanding and not subject to redemption if the Company redeems less than all of the Notes	$ 150,000,000
Effective interest rate	0.80%
Remaining life of debt discount and issuance cost accretion		2 years 2 months 12 days
Maximum number of shares issuable upon conversion (in shares) | shares	5,900,000
Convertible Senior Notes | Convertible Debt | Period 1
Debt Instrument [Line Items]
Threshold trading days | day	20
Threshold consecutive trading days | day	30
Threshold percentage of stock price trigger	130%
Convertible Senior Notes | Convertible Debt | Period 2
Debt Instrument [Line Items]
Threshold trading days | day	5
Threshold consecutive trading days | day	10
Threshold percentage of stock price trigger	98%

Convertible Senior Notes - Conv

Convertible Senior Notes - Convertible Debt Balances (Details) - Convertible Debt - Convertible Senior Notes - USD ($)	Jun. 30, 2023	Dec. 31, 2022	Sep. 25, 2020
Debt Instrument [Line Items]
Principal amount	$ 575,000,000	$ 575,000,000	$ 575,000,000
Unamortized debt issuance costs	(6,886,000)	(8,429,000)
Convertible senior notes, net	$ 568,114,000	$ 566,571,000

Convertible Senior Notes - Summ

Convertible Senior Notes - Summary of Components of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Debt Instrument [Line Items]
Amortization of debt issuance costs			$ 2,091	$ 2,079
Convertible Senior Notes | Convertible Debt
Debt Instrument [Line Items]
Contractual coupon interest	$ 359	$ 359	719	719
Amortization of debt issuance costs	$ 772	$ 766	$ 1,543	$ 1,530

Lessor Leases - Narrative (Deta

Lessor Leases - Narrative (Details)	6 Months Ended
	Jun. 30, 2023
Lease Receivable | Customer Concentration Risk | U.S. Government Hospitals
Lessor, Lease, Description [Line Items]
Concentration risk percentage	26%
Minimum
Lessor, Lease, Description [Line Items]
Term of sales-type leases	1 year
Maximum
Lessor, Lease, Description [Line Items]
Term of sales-type leases	10 years

Lessor Leases - Income Recogniz

Lessor Leases - Income Recognized from Sales-Type Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Sales-type lease revenues	$ 7,856	$ 17,413	$ 13,572	$ 23,918
Cost of sales-type lease revenues	(4,380)	(8,528)	(7,042)	(11,606)
Selling profit on sales-type lease revenues	$ 3,476	$ 8,885	$ 6,530	$ 12,312

Lessor Leases - Components of S

Lessor Leases - Components of Sales-Type Lease Receivables (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Net minimum lease payments to be received	$ 53,675	$ 50,755
Less: Unearned interest income portion	(7,558)	(6,345)
Net investment in sales-type leases	46,117	44,410
Less: Current portion	(11,078)	(11,486)
Long-term investment in sales-type leases, net	$ 35,039	$ 32,924

Lessor Leases - Maturity Schedu

Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Remaining six months of 2023	$ 6,956
2024	11,780
2025	9,360
2026	7,727
2027	6,280
Thereafter	11,572
Net minimum lease payments to be received	53,675	$ 50,755
Present value adjustment	(7,558)	$ (6,345)
Total net investment in sales-type leases	$ 46,117

Lessor Leases - Income Recogn_2

Lessor Leases - Income Recognized from Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Rental income	$ 1,870	$ 2,421	$ 4,129	$ 4,893

Lessee Leases - Narrative (Deta

Lessee Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Lessee, Lease, Description [Line Items]
Operating lease cost	$ 2,600	$ 4,700	$ 5,600	$ 8,800
Impairment and abandonment of operating lease right-of-use assets related to facilities		$ 3,300	$ 7,815	$ 5,093
Minimum
Lessee, Lease, Description [Line Items]
Term of operating leases	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Term of operating leases	12 years		12 years

Lessee Leases - Maturity Schedu

Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Remaining six months of 2023	$ 6,721
2024	12,388
2025	9,664
2026	8,996
2027	7,340
Thereafter	8,084
Total operating lease payments	53,193
Present value adjustment	(6,732)
Total operating lease liabilities	46,461
Current portion of operating lease liabilities	10,951	$ 10,761
Long-term portion of operating lease liabilities	$ 35,510	$ 39,405
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities

Lessee Leases - Supplemental Ca

Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of lease liabilities	$ 6,725	$ 8,607
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 1,608	$ 10,685

Lessee Leases - Weighted-Averag

Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details)	Jun. 30, 2023	Dec. 31, 2022
Leases [Abstract]
Weighted-average remaining lease term	4 years 9 months 18 days	5 years
Weighted-average discount rate	5.70%	5.70%

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions		3 Months Ended
	Apr. 06, 2023	Jun. 30, 2022	Jun. 30, 2023
Loss Contingencies [Line Items]
Non-cancelable purchase commitments			$ 127.1
Non-cancelable purchase commitments expected to be paid within the year			106.9
Loss contingency, expense		$ 12.5
Expected insurance recoveries		11.1
Loss contingency, expense incurred to date			13.6
Loss contingency, cumulative expected insurance recoveries			11.1
Loss contingency, cumulative insurance recoveries received			$ 10.9
Litigation settlement, amount awarded to other party	$ 4.3
Cost of product and service revenues
Loss Contingencies [Line Items]
Ransomware incident, expense, net of insurance recoveries		0.2
Selling, general, and administrative
Loss Contingencies [Line Items]
Ransomware incident, expense, net of insurance recoveries		$ 1.2

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ 8,758	$ 1,705	$ 2,576	$ (1,538)
Annual effective tax rate			1.70%	24.10%
Tax expense (benefit)			$ 2,700	$ (5,300)
Unrecognized tax benefits	10,000		10,000		$ 9,300
Accrued interest and penalties	$ 300		$ 300		$ 200

Employee Benefits and Share-B_3

Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	$ 14,089	$ 17,213	$ 28,131	$ 33,421
Cost of product and service revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	2,268	2,160	4,276	4,404
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	1,697	2,594	3,303	4,858
Selling, general, and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based compensation expense	$ 10,124	$ 12,459	$ 20,552	$ 24,159

Employee Benefits and Share-B_4

Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares (Details) - ESPP shares available for future issuance - 1997 Plan	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility (minimum)	31.70%	28.80%	31.70%	28.80%
Expected volatility (maximum)	63.90%	45.60%	63.90%	45.60%
Risk-free interest rate (minimum)	0.10%	0.10%	0.10%	0.10%
Risk-free interest rate (maximum)	5.10%	1.50%	5.10%	1.50%
Dividend yield	0%	0%	0%	0%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	6 months	6 months	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	2 years	2 years	2 years	2 years

Employee Benefits and Share-B_5

Employee Benefits and Share-Based Compensation - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Aug. 02, 2016	Nov. 04, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, amount capitalized	$ 1,100,000		$ 2,200,000
The 2016 Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of shares authorized for repurchase under stock repurchase programs (up to)					$ 50,000,000
Remaining value of shares authorized for repurchase under stock repurchase programs	$ 2,700,000		$ 2,700,000
Number of shares repurchased (in shares)	0	0	0	389,300
Average price of repurchased shares (in dollars per share)				$ 134.11
Aggregate purchase price of treasury stock				$ 52,200,000
2014 Share Repurchase Program
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Value of shares authorized for repurchase under stock repurchase programs (up to)						$ 50,000,000
1997 Plan | ESPP shares available for future issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares purchased under ESPP (in shares)			209,000	175,000
Weighted-average price of shares purchased (in dollars per share)			$ 46.96	$ 66.81
Unrecognized compensation cost	$ 2,600,000		$ 2,600,000
Weighted average period of compensation cost not yet recognized			1 year 4 months 24 days
2009 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted (in shares)	0	0	200,000	0
Weighted-average fair value of options granted (in dollars per share)			$ 19.48
Intrinsic value of options exercised	$ 1,300,000	$ 2,800,000	$ 2,600,000	$ 15,500,000
Unrecognized compensation cost of unvested stock options	12,600,000		$ 12,600,000
2009 Plan | Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of compensation cost not yet recognized			1 year 1 month 6 days
2009 Plan | RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of compensation cost not yet recognized			2 years 10 months 24 days
Unrecognized compensation cost	95,400,000		$ 95,400,000
2009 Plan | RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of compensation cost not yet recognized			10 months 24 days
Unrecognized compensation cost	1,200,000		$ 1,200,000
2009 Plan | PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average period of compensation cost not yet recognized			1 year 7 months 6 days
Unrecognized compensation cost	$ 8,700,000		$ 8,700,000

Employee Benefits and Share-B_6

Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details) - Stock Options	6 Months Ended
	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	3 years 2 months 12 days
Expected volatility	44.80%
Risk-free interest rate	3.70%
Estimated forfeiture rate	10%
Dividend yield	0%

Employee Benefits and Share-B_7

Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details) - 2009 Plan - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Number of Shares
Outstanding at beginning of period (in shares)			2,434,000
Granted (in shares)	0	0	200,000	0
Exercised (in shares)			(130,000)
Expired (in shares)			(72,000)
Forfeited (in shares)			(119,000)
Outstanding at end of period (in shares)	2,313,000		2,313,000		2,434,000
Exercisable at end of period (in shares)	1,863,000		1,863,000
Vested and expected to vest at end of period (in shares)	2,282,000		2,282,000
Weighted-Average Exercise Price
Outstanding at beginning of period (in dollars per share)			$ 68.65
Granted (in dollars per share)			55.60
Exercised (in dollars per share)			41.54
Expired (in dollars per share)			77.54
Forfeited (in dollars per share)			80.50
Outstanding at end of period (in dollars per share)	$ 68.16		68.16		$ 68.65
Exercisable at end of period (in dollars per share)	66.78		66.78
Vested and expected to vest at end of period (in dollars per share)	$ 68.10		$ 68.10
Weighted-Average Remaining Years
Outstanding			5 years 3 months 18 days		6 years 1 month 6 days
Exercisable			5 years 1 month 6 days
Vested and expected to vest			5 years 3 months 18 days
Aggregate Intrinsic Value
Outstanding	$ 26,912		$ 26,912		$ 7,887
Exercisable	23,098		23,098
Vested and expected to vest	$ 26,591		$ 26,591

Employee Benefits and Share-B_8

Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - RSUs - 2009 Plan - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Number of Shares
Outstanding at beginning of period (in shares)	1,117
Granted (Awarded) (in shares)	244
Vested (Released) (in shares)	(129)
Forfeited (in shares)	(237)
Outstanding and unvested at end of period (in shares)	995	1,117
Weighted-Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share)	$ 115.75
Granted (Awarded) (in dollars per share)	67.10
Vested (Released) (in dollars per share)	124.31
Forfeited (in dollars per share)	114.73
Outstanding and unvested at end of period (in dollars per share)	$ 103	$ 115.75
Weighted-Average Remaining Years
Outstanding and unvested	1 year 6 months	1 year 7 months 6 days
Aggregate Intrinsic Value
Outstanding and unvested	$ 73,319	$ 56,297

Employee Benefits and Share-B_9

Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details) - RSAs - 2009 Plan shares in Thousands	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Number of Shares
Outstanding at beginning of period (in shares) | shares	13
Granted (Awarded) (in shares) | shares	21
Vested (Released) (in shares) | shares	(13)
Outstanding and unvested at end of period (in shares) | shares	21
Weighted-Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 109.39
Granted (Awarded) (in dollars per share) | $ / shares	72.02
Vested (Released) (in dollars per share) | $ / shares	109.39
Outstanding and unvested at end of period (in dollars per share) | $ / shares	$ 72.02

Employee Benefits and Share-_10

Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details) - Performance-Based Restricted Stock - 2009 Plan shares in Thousands	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Number of Shares
Outstanding at beginning of period (in shares) | shares	135
Granted (Awarded) (in shares) | shares	65
Vested (Released) (in shares) | shares	(30)
Forfeited (in shares) | shares	(63)
Outstanding and unvested at end of period (in shares) | shares	107
Weighted-Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 147.42
Granted (Awarded) (in dollars per share) | $ / shares	122.29
Vested (Released) (in dollars per share) | $ / shares	139.58
Forfeited (in dollars per share) | $ / shares	153.89
Outstanding and unvested at end of period (in dollars per share) | $ / shares	$ 130.59

Employee Benefits and Share-_11

Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details) shares in Thousands	Jun. 30, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	9,762
Stock options outstanding
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	2,313
Non-vested restricted stock awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	1,123
Shares authorized for future issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	2,932
ESPP shares available for future issuance
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	3,394

Restructuring Expenses - Narrat

Restructuring Expenses - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 721,000	$ 0	$ 6,035,000	$ 3,527,000
Q1 2022 Plan
Restructuring Cost and Reserve [Line Items]
Restructuring expenses				$ 3,500,000
Unpaid balance related to restructuring plan	0		0
Q4 2022/Q1 2023 Plan
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	700,000		6,000,000
Restructuring and related cost, cost incurred to date	23,500,000		23,500,000
Unpaid balance related to restructuring plan	$ 2,800,000		$ 2,800,000		$ 18,200,000

Restructuring Expenses - Total

Restructuring Expenses - Total Restructuring Expense Recognized in the Condensed Consolidated Statements of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 721	$ 0	$ 6,035	$ 3,527
Cost of product and service revenues
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	238	0	382	156
Research and development
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	7	0	492	1,594
Selling, general, and administrative
Restructuring Cost and Reserve [Line Items]
Restructuring expenses	$ 476	$ 0	$ 5,161	$ 1,777